A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP-690,550.
Inclusion Criteria:
Exclusion Criteria:
Ypsilanti, Michigan 48197, United States
Houston, Texas 77030, United States
Milwaukee, Wisconsin 53215, United States
Calgary, Alberta T2N 4Z6, Canada
Edmonton, Alberta T6G 2B7, Canada
Berlin, 13353, Germany
Békéscsaba, 5600, Hungary
Budapest, 1076, Hungary
Budapest, 1125, Hungary
Gyula, 5700, Hungary
Szeged, 6720, Hungary
Higashi-ibaraki-gun, Ibaraki 311-3193, Japan
Takatsuki-shi, Osaka 569-8686, Japan
Bunkyo-ku, Tokyo 113-8519, Japan
Minato-ku, Tokyo 105-8471, Japan
Minato-ku, Tokyo 108-8642, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
Tauranga, Bay of Plenty 3112, New Zealand
Bydgoszcz, Kuyavian-Pomeranian Voivodeship 85-168, Poland
Warsaw, Masovian Voivodeship 02-507, Poland
Bialystok, Podlaskie Voivodeship 15-950, Poland
Lodz, 90-153, Poland
Bucharest, 050098, Romania
Moscow, 123423, Russia
Moscow, 129110, Russia
Nizhny Novgorod, 603126, Russia
Novosibirsk, 630117, Russia
Novosibirsk, 630117, Russia
Samara, 443029, Russia
Yaroslavl, 150062, Russia
Belgrade, 11000, Serbia
Dnipropetrovsk, 49074, Ukraine
Lviv, 79059, Ukraine
Odesa, 65025, Ukraine
Odesa, 65059, Ukraine
Uzhhorod, 88009, Ukraine
Vinnytsia, 21005, Ukraine
Cambridge, England CB2 0QQ, United Kingdom
Norwich, Norfolk NR4 7UY, United Kingdom